FDA Clears OTC Glucose Monitoring System for Weight Management
System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in real time
Use of Vaginal Estradiol Tablets Not Linked to Recurrent Stroke
Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education
OTC Oral Contraceptive Pills Improve Access to Effective Contraception
OTC access linked to 31.8 percentage point increase in individuals moving from no contraceptive method to an effective method
FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis
Papzimeos is the first and only FDA-approved therapy for the treatment of adults with recurrent respiratory papillomatosis
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
TAR-200 monotherapy was well tolerated, with high complete response rate and prolonged disease-free survival
Molgramostim Beneficial in Autoimmune Pulmonary Alveolar Proteinosis
Once-daily inhaled molgramostim leads to greater increase in pulmonary gas transfer than placebo
Stapokibart Found to Be Superior to Placebo for Severe Chronic Rhinosinusitis With Polyps
Benefits include reduced polyp size and severity of nasal symptoms at 24 weeks
AAP Issues New Vaccine Guidelines That Differ From U.S. Government Advice
FDA Approves Wegovy to Treat Serious Liver Disease
Adults With Hearing Loss Using Hearing Aids Have Reduced Dementia Risk
Among those younger than 70 years at the time of HL diagnosis, risk for incident dementia was 61 percent lower for those with hearing aids
